Valuation: Precipio, Inc.

Market Cap 38.27M 34.01M 31.53M 28.68M 54.13M 3.63B 54.99M 379M 149M 1.9B 144M 141M 6.04B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 39.27M 34.9M 32.35M 29.43M 55.54M 3.73B 56.43M 389M 152M 1.94B 147M 144M 6.2B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day-5.17%
1 week-7.55%
Current month-9.73%
1 month-19.22%
3 months-13.25%
6 months-24.47%
Current year-6.98%
1 week 21.38
Extreme 21.375
23.17
1 month 21.38
Extreme 21.375
27.04
Current year 19.22
Extreme 19.22
33.63
1 year 18
Extreme 18
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
53
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 A Free

Director

520 0.0291%
7/15/26 A Free

Director

416 0.0233%
7/15/26 A Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-5.17%-7.55%+23.91%+219.99% 38.27M
-0.93%+4.86%+28.03%+47.67% 255B
-1.06%+4.20%+9.56%+11.84% 161B
-0.27%+0.65%-4.36%+54.87% 151B
+0.57%+3.88%-55.27%-12.46% 64.33B
+1.47%+5.90%-13.25%-12.40% 51.9B
-0.85%+4.81%+9.39%+50.51% 50.25B
-1.70%+1.63%+16.02%+24.23% 49.92B
-1.47%+1.42%+21.88%+59.26% 48.77B
-1.62%+0.73%+30.59%+75.83% 42.93B
Average -1.10%+2.33%+6.65%+51.93% 87.5B
Weighted average by Cap. -0.69%+3.56%+8.51%+35.19%

Financials

2024 2025
Net sales 18.53M 16.47M 15.27M 13.89M 26.21M 1.76B 26.63M 184M 71.96M 918M 69.55M 68.07M 2.93B 24.05M 21.38M 19.81M 18.03M 34.02M 2.28B 34.56M 238M 93.38M 1.19B 90.26M 88.33M 3.8B
Net income -4.29M -3.81M -3.53M -3.22M -6.07M -407M -6.17M -42.49M -16.66M -212M -16.1M -15.76M -677M -363K -323K -299K -272K -513K -34.45M -522K -3.59M -1.41M -17.98M -1.36M -1.33M -57.31M
Net Debt -136K -121K -112K -102K -192K -12.91M -195K -1.35M -528K -6.74M -510K -500K -21.47M 1M 891K 826K 751K 1.42M 95.1M 1.44M 9.92M 3.89M 49.63M 3.76M 3.68M 158M
Projected Income Statement - Annual - Precipio, Inc.
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
16/10/26 $21.38 -5.17% 95,133
15/10/26 $22.54 +1.30% 45,182
14/10/26 $22.25 -1.51% 42,510
13/10/26 $22.59 0.00% 29,986
12/10/26 $22.59 -2.29% 11,974
  1. Stock Market
  2. Stocks
  3. PRPO Stock